<!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" class="fa-events-icons-ready" lang="en"><head>  
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <meta name="referrer" content="origin-when-cross-origin">
  <title>Entinostat and Anastrozole in Treating Postmenopausal Women 
With TNBC That Can Be Removed by Surgery - No Study Results Posted - 
ClinicalTrials.gov</title>
    <link href="https://clinicaltrials.gov/ct2/show/results/NCT01234532" rel="canonical">
    

  <!-- Open Graph data -->
  <meta property="og:type" content="article">
  <meta property="og:title" content="Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery - No Study Results Posted - ClinicalTrials.gov">
  <meta property="og:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-logo.png">
    <meta property="og:description" content="Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery - No Study Results Posted.">
  <meta property="og:url" content="https://clinicaltrials.gov/ct2/show/results/NCT01234532">
    
  <link rel="shortcut icon" href="https://clinicaltrials.gov/ct2/html/images/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-144x144.png" sizes="144x144">
  <link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-114x114.png" sizes="114x114">
  <link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-72x72.png" sizes="72x72">
  <link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-precomposed.png">
  <link rel="apple-touch-icon-precomposed" href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon.png">

  <link rel="stylesheet" type="text/css" href="reportedlate_cancelledresubmitted_same_day_files/superfish.css" media="screen">
  <link rel="stylesheet" type="text/css" href="reportedlate_cancelledresubmitted_same_day_files/superfish-vertical.css" media="screen">
  <link rel="stylesheet" type="text/css" href="reportedlate_cancelledresubmitted_same_day_files/glossary.css">
  <link rel="stylesheet" type="text/css" href="reportedlate_cancelledresubmitted_same_day_files/base.css">
  <link rel="stylesheet" type="text/css" href="reportedlate_cancelledresubmitted_same_day_files/print.css" media="print">
  <link rel="stylesheet" href="reportedlate_cancelledresubmitted_same_day_files/w3-ct.css" type="text/css">
  <!--[if lt IE 9]>
	<link rel="stylesheet" href="/ct2/html/css/w3-ct-oldIE.css?v=41" type="text/css" />
  <![endif]-->
   	
  <link rel="preconnect" href="https://use.fontawesome.com/">
  <link rel="preconnect" href="https://www.ncbi.nlm.nih.gov/">
  <link rel="preconnect" href="http://www.ncbi.nlm.nih.gov/">
  
  <script src="reportedlate_cancelledresubmitted_same_day_files/20a31629ec.js"></script><link href="reportedlate_cancelledresubmitted_same_day_files/20a31629ec.css" media="all" rel="stylesheet">
<!--[if lte IE 7]>
       <link href="/ct2/html/css/target-IE7-and-below.css" rel="stylesheet" type="text/css">
<![endif]-->

<style type="text/css">
  h2 
  {
      background-color: #EAEAEA;
  }
</style>















		








<link href="reportedlate_cancelledresubmitted_same_day_files/data-entry.css" rel="stylesheet" type="text/css">

<link href="reportedlate_cancelledresubmitted_same_day_files/trial-record.css" rel="stylesheet" type="text/css">

	<script type="text/javascript" src="reportedlate_cancelledresubmitted_same_day_files/jquery.js"></script><noscript></noscript>
<script type="text/javascript" async="" src="reportedlate_cancelledresubmitted_same_day_files/superclick.js"></script><noscript></noscript>
<script type="text/javascript" async="" src="reportedlate_cancelledresubmitted_same_day_files/ct.js"></script><noscript></noscript>
<script type="text/javascript" async="" src="reportedlate_cancelledresubmitted_same_day_files/ctmenu.js"></script><noscript></noscript>

<script>
var theURL = "/ct2/show/results/NCT01234532"+window.location.hash;
history.replaceState(null,null,theURL);
</script>

  <meta name="ncbi_sid" content="86181169e1ad7cd6_1e6c67SID">
  <meta name="ncbi_app" content="ctgov">
  <meta name="ncbi_db" content="ctgov">
  <meta name="ncbi_pdid" content="show_results">
  <meta name="ncbi_pcid" content="NCT01234532">
  <meta name="ncbi_ctreqid" content="RRd0HFiO">
  <meta name="ncbi_ctsessid" content="SRd0E2Zy">
  <meta name="ncbi_ctipid" content="IVMl0ypF">
  <meta name="ncbi_cthost" content="wp3">
<script async="1" src="reportedlate_cancelledresubmitted_same_day_files/analytics.js"></script><style></style></head>


<body> 
<!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET-->
<script type="text/javascript">
(function(){var g=function(e,h,f,g){
this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};
this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};
this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};
this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&t=" + (new Date()).getTime();document.body&&document.body.appendChild(a)}};
this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){a.go()})}};
try{(new g(100,"r","QSI_S_ZN_7WHWRcRMBs9xWYd","https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd")).start()}catch(i){}})();
</script><div id="ZN_7WHWRcRMBs9xWYd"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div>
<!--END WEBSITE FEEDBACK SNIPPET-->
<div id="glossary" class="glossary" aria-describedby="glossary-result" aria-hidden="true">
  <button title="Close glossary" class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled" tabindex="-1"><span class="usa-sr-only">Hide glossary</span>
    <i class="fa fa-times" aria-hidden="true"></i>
  </button>
  <h4 class="glossary-heading">Glossary</h4>
  <p>
  Study record managers: refer to the <a href="https://clinicaltrials.gov/ct2/manage-recs/resources#DataElement" tabindex="-1"><span style="text-decoration:underline">Data Element Definitions</span></a> if submitting registration or results information.
  </p>
  <p>
  <label for="glossary-search" class="label">Search for terms</label>
  </p>
  <span class="clearable-input">
  <input id="glossary-search" class="js-glossary-search" tabindex="-1">
   <span data-clear-input="" class="js-glossary-clear button js-glossary-toggle usa-button-unstyled">x</span>
  </span>
  <div class="glossary__content" id="glossary-result">
    <ul class="js-glossary-list"><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-0" aria-expanded="false">Accepts healthy volunteers</button><div class="glossary__definition" id="glossary-content-0" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span> that indicates whether people who do not have the <span class="term" data-term="condition/disease" title="Show definition" tabindex="-1">condition/disease</span> being studied can participate in that clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-1" aria-expanded="false">Active comparator arm</button><div class="glossary__definition" id="glossary-content-1" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" title="Show definition" tabindex="-1">arm type</span> in which a group of participants receives an <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> considered to be effective (or active) by health care providers.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-2" aria-expanded="false">Adverse event</button><div class="glossary__definition" id="glossary-content-2" aria-hidden="true" style="display: none;">An
 unfavorable change in the health of a participant, including abnormal 
laboratory findings, that happens during a clinical study or within a 
certain amount of time after the study has ended. This change may or may
 not be caused by the <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-3" aria-expanded="false">Age or age group</button><div class="glossary__definition" id="glossary-content-3" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span>
 that indicates the age a person must be to participate in a clinical 
study. This may be indicated by a specific age or the following age 
groups:<p>The age groups are: </p><ul><li>Child (birth-17)</li><li>Adult (18-64)</li><li style="margin-bottom:-.4em;">Older Adult (65+)</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-4" aria-expanded="false">All-cause mortality</button><div class="glossary__definition" id="glossary-content-4" aria-hidden="true" style="display: none;">A measure of all deaths, due to any cause, that occur during a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-5" aria-expanded="false">Allocation</button><div class="glossary__definition" id="glossary-content-5" aria-hidden="true" style="display: none;">A method used to assign participants to an arm of a clinical study. The types of allocation are <span class="term" data-term="randomized allocation" title="Show definition" tabindex="-1">randomized allocation</span> and nonrandomized.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-6" aria-expanded="false">Arm</button><div class="glossary__definition" id="glossary-content-6" aria-hidden="true" style="display: none;">A group or subgroup of participants in a clinical trial that receives a specific <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span>, or no intervention, according to the trial's <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-7" aria-expanded="false">Arm type</button><div class="glossary__definition" id="glossary-content-7" aria-hidden="true" style="display: none;">A
 general description of the clinical trial arm. It identifies the role 
of the intervention that participants receive. Types of arms include <span class="term" data-term="experimental arm" title="Show definition" tabindex="-1">experimental arm</span>, <span class="term" data-term="active comparator arm" title="Show definition" tabindex="-1">active comparator arm</span>, <span class="term" data-term="placebo comparator arm" title="Show definition" tabindex="-1">placebo comparator arm</span>, <span class="term" data-term="sham comparator arm" title="Show definition" tabindex="-1">sham comparator arm</span>, and <span class="term" data-term="no intervention arm" title="Show definition" tabindex="-1">no intervention arm</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-8" aria-expanded="false">Baseline characteristics</button><div class="glossary__definition" id="glossary-content-8" aria-hidden="true" style="display: none;">Data
 collected at the beginning of a clinical study for all participants and
 for each arm or comparison group. These data include demographics, such
 as age, sex/gender, race and ethnicity, and study-specific measures 
(for example, systolic blood pressure, prior antidepressant treatment).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-9" aria-expanded="false">Canceled submission</button><div class="glossary__definition" id="glossary-content-9" aria-hidden="true" style="display: none;">Indicates that the study sponsor or investigator recalled a submission of <span class="term" data-term="study results" title="Show definition" tabindex="-1">study results</span> before <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span> took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> cannot be modified until QC review is completed, unless the submission is canceled.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-10" aria-expanded="false">Certain agreements</button><div class="glossary__definition" id="glossary-content-10" aria-hidden="true" style="display: none;">Information required by the <span class="term" data-term="food and drug administration amendments act of 2007, section 801 (fdaaa 801)" title="Show definition" tabindex="-1">Food and Drug Administration Amendments Act of 2007</span>. In general, this is a description of any agreement between the sponsor of a clinical study and the <span class="term" data-term="principal investigator (pi)" title="Show definition" tabindex="-1">principal investigator</span>
 (PI) that does not allow the PI to discuss the results of the study or 
publish the study results in a scientific or academic journal after the 
study is completed.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-11" aria-expanded="false">Certification</button><div class="glossary__definition" id="glossary-content-11" aria-hidden="true" style="display: none;">A
 sponsor or investigator may submit a certification to delay submission 
of results information if they are applying for FDA approval of a new 
drug or device, or new use of an already approved drug or device. A 
sponsor or investigator who submits a certification can delay results 
submission up to 2 years after the <span class="term" data-term="certification/extension first submitted" title="Show definition" tabindex="-1">certification/extension first submitted</span> date, unless certain events occur sooner. See <a href="https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType" style="text-decoration:underline dotted" target="_blank" tabindex="-1">Delay Results Type</a> in the Results Data Element definitions for more information about this certification.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-12" aria-expanded="false">Certification/extension first posted</button><div class="glossary__definition" id="glossary-content-12" aria-hidden="true" style="display: none;">The date on which information about a <span class="term" data-term="certification" title="Show definition" tabindex="-1">certification</span> to delay submission of results or an <span class="term" data-term="extension request" title="Show definition" tabindex="-1">extension request</span>
 was first available on ClinicalTrials.gov. ClinicalTrials.gov does not 
indicate whether the submission was a certification or extension 
request. There is typically a delay between the date the study sponsor 
or investigator submitted the certification or extension request and the
 <span class="term" data-term="first posted" title="Show definition" tabindex="-1">first posted date</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-13" aria-expanded="false">Certification/extension first submitted</button><div class="glossary__definition" id="glossary-content-13" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" title="Show definition" tabindex="-1">certification</span> or an <span class="term" data-term="extension request" title="Show definition" tabindex="-1">extension request</span>
 to delay submission of results. A sponsor or investigator who submits a
 certification can delay results submission up to 2 years after this 
date, unless certain events occur sooner. There is typically a delay 
between the date the certification or extension request was submitted 
and the date the information is first available on ClinicalTrials.gov (<span class="term" data-term="certification/extension first posted" title="Show definition" tabindex="-1">certification/extension first posted</span>).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-14" aria-expanded="false">Certification/extension first submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-14" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" title="Show definition" tabindex="-1">certification</span> or an <span class="term" data-term="extension request" title="Show definition" tabindex="-1">extension request</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span>
 criteria. The sponsor or investigator may need to revise and submit a 
certification or extension request one or more times before NLM's QC 
review criteria are met. It is the responsibility of the sponsor or 
investigator to ensure that the study record is consistent with the NLM 
QC review criteria. Meeting QC criteria for an extension request does 
not mean that the National Institutes of Health (NIH) has determined 
that the request demonstrates good cause. The process for review and 
granting of extension requests by the NIH is being developed.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-15" aria-expanded="false">City and distance</button><div class="glossary__definition" id="glossary-content-15" aria-hidden="true" style="display: none;">In
 the search feature, the City field is used to find clinical studies 
with locations in a specific city. The Distance field is used to find 
studies with locations within the specified distance from a city in 
number of miles. For example, if you choose Illinois as the <span class="term" data-term="state" title="Show definition" tabindex="-1">state</span>,
 identifying "Chicago" as the city and "100 miles" as the distance will 
find all studies listing a location within 100 miles of Chicago.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-16" aria-expanded="false">Clinical study</button><div class="glossary__definition" id="glossary-content-16" aria-hidden="true" style="display: none;">A
 research study involving human volunteers (also called participants) 
that is intended to add to medical knowledge. There are two types of 
clinical studies: <span class="term" data-term="interventional study (clinical trial)" title="Show definition" tabindex="-1">interventional studies</span> (also called clinical trials) and <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational studies</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-17" aria-expanded="false">Clinical trial</button><div class="glossary__definition" id="glossary-content-17" aria-hidden="true" style="display: none;">Another name for an <span class="term" data-term="interventional study (clinical trial)" title="Show definition" tabindex="-1">interventional study</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-18" aria-expanded="false">ClinicalTrials.gov identifier (NCT number)</button><div class="glossary__definition" id="glossary-content-18" aria-hidden="true" style="display: none;">The unique identification code given to each clinical study upon <span class="term" data-term="registration" title="Show definition" tabindex="-1">registration</span> at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-19" aria-expanded="false">Collaborator</button><div class="glossary__definition" id="glossary-content-19" aria-hidden="true" style="display: none;">An organization other than the <span class="term" data-term="sponsor" title="Show definition" tabindex="-1">sponsor</span>
 that provides support for a clinical study. This support may include 
activities related to funding, design, implementation, data analysis, or
 reporting.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-20" aria-expanded="false">Condition/disease</button><div class="glossary__definition" id="glossary-content-20" aria-hidden="true" style="display: none;">The
 disease, disorder, syndrome, illness, or injury that is being studied. 
On ClinicalTrials.gov, conditions may also include other health-related 
issues, such as lifespan, quality of life, and health risks.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-21" aria-expanded="false">Contact</button><div class="glossary__definition" id="glossary-content-21" aria-hidden="true" style="display: none;">The
 name and contact information for the person who can answer enrollment 
questions for a clinical study. Each location where the study is being 
conducted may also have a specific contact, who may be better able to 
answer those questions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-22" aria-expanded="false">Country</button><div class="glossary__definition" id="glossary-content-22" aria-hidden="true" style="display: none;">In
 the search feature, the Country field is used to find clinical studies 
with locations in a specific country. For example,  if you choose the 
United States, you can then narrow your search by selecting a <span class="term" data-term="state" title="Show definition" tabindex="-1">state</span> and identifying a <span class="term" data-term="city and distance" title="Show definition" tabindex="-1">city and distance</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-23" aria-expanded="false">Cross-over assignment</button><div class="glossary__definition" id="glossary-content-23" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" title="Show definition" tabindex="-1">intervention model</span>
 describing a clinical trial in which groups of participants receive two
 or more interventions in a specific order. For example, two-by-two 
cross-over assignment involves two groups of participants. One group 
receives drug A during the initial phase of the trial, followed by drug B
 during a later phase. The other group receives drug B during the 
initial phase, followed by drug A. So during the trial, participants 
"cross over" to the other drug. All participants receive drug A and drug
 B at some point during the trial but in a different order, depending on
 the group to which they are assigned.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-24" aria-expanded="false">Data Monitoring Committee (DMC)</button><div class="glossary__definition" id="glossary-content-24" aria-hidden="true" style="display: none;">A group of independent scientists who monitor the safety and scientific integrity of a <span class="term" data-term="clinical trial" title="Show definition" tabindex="-1">clinical trial</span>.
 The DMC can recommend to the sponsor that the trial be stopped if it is
 not effective, is harming participants, or is unlikely to serve its 
scientific purpose. Members are chosen based on the scientific skills 
and knowledge needed to monitor the particular trial. Also called a data
 safety and monitoring board, or DSMB.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-25" aria-expanded="false">Early Phase 1 (formerly listed as Phase 0)</button><div class="glossary__definition" id="glossary-content-25" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" title="Show definition" tabindex="-1">phase</span> of research used to describe exploratory trials conducted before traditional <span class="term" data-term="phase 1" title="Show definition" tabindex="-1">phase 1</span>
 trials to investigate how or whether a drug affects the body. They 
involve very limited human exposure to the drug and have no therapeutic 
or diagnostic goals (for example, screening studies, microdose studies).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-26" aria-expanded="false">Eligibility criteria</button><div class="glossary__definition" id="glossary-content-26" aria-hidden="true" style="display: none;">The
 key requirements that people who want to participate in a clinical 
study must meet or the characteristics they must have. Eligibility 
criteria consist of both <span class="term" data-term="inclusion criteria" title="Show definition" tabindex="-1">inclusion criteria</span> (which are required for a person to participate in the study) and <span class="term" data-term="exclusion criteria" title="Show definition" tabindex="-1">exclusion criteria</span> (which prevent a person from participating). Types of eligibility criteria include whether a study <span class="term" data-term="accepts healthy volunteers" title="Show definition" tabindex="-1"> accepts healthy volunteers</span>, has <span class="term" data-term="age or age group" title="Show definition" tabindex="-1">age or age group</span> requirements, or is limited by <span class="term" data-term="sex" title="Show definition" tabindex="-1">sex</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-27" aria-expanded="false">Enrollment</button><div class="glossary__definition" id="glossary-content-27" aria-hidden="true" style="display: none;">The
 number of participants in a clinical study. The "estimated" enrollment 
is the target number of participants that the researchers need for the 
study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-28" aria-expanded="false">Exclusion criteria</button><div class="glossary__definition" id="glossary-content-28" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span>. These are reasons that a person is not allowed to participate in a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-29" aria-expanded="false">Expanded access</button><div class="glossary__definition" id="glossary-content-29" aria-hidden="true" style="display: none;">A
 way for patients with serious diseases or conditions who cannot 
participate in a clinical trial to gain access to a medical product that
 has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">U.S. Food and Drug Administration (FDA)</span>. Also called compassionate use.  There are different <span class="term" data-term="expanded access type" title="Show definition" tabindex="-1">expanded access types</span>. <p style="margin-bottom:-.4em;">For more information, see FDA <a href="https://www.fda.gov/news-events/public-health-focus/expanded-access" style="text-decoration:underline dotted" target="_blank" tabindex="-1">Expanded Access: Information for Patients</a>.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-30" aria-expanded="false">Expanded access status</button><div class="glossary__definition" id="glossary-content-30" aria-hidden="true" style="display: none;"><ul><li><strong>Available:</strong> <span class="term" data-term="expanded access" title="Show definition" tabindex="-1">Expanded access</span>
 is currently available for this investigational treatment, and patients
 who are not participants in the clinical study may be able to gain 
access to the drug, biologic, or medical device being studied.</li><li><strong>No longer available:</strong> <span class="term" data-term="expanded access" title="Show definition" tabindex="-1">Expanded access</span> was available for this intervention previously but is not currently available and will not be available in the future.</li><li><strong>Temporarily not available:</strong> <span class="term" data-term="expanded access" title="Show definition" tabindex="-1">Expanded access</span> is not currently available for this intervention but is expected to be available in the future.</li><li><strong>Approved for marketing:</strong> The intervention has been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1"> U.S. Food and Drug Administration</span> for use by the public.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-31" aria-expanded="false">Expanded access type</button><div class="glossary__definition" id="glossary-content-31" aria-hidden="true" style="display: none;">Describes the category of <span class="term" data-term="expanded access" title="Show definition" tabindex="-1">expanded access</span> under <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">U.S. Food and Drug Administration (FDA)</span> regulations. There are three types of expanded access: <ul><li><strong>Individual Patients</strong>:
 Allows a single patient, with a serious disease or condition who cannot
 participate in a clinical trial, access to a drug or biological product
 that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">FDA</span>. This category also includes access in an emergency situation.</li><li><strong>Intermediate-size Population</strong>:
 Allows more than one patient (but generally fewer patients than through
 a Treatment IND/Protocol) access to a drug or biological product that 
has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">FDA</span>.
  This type of expanded access is used when multiple patients with the 
same disease or condition seek access to a specific drug or biological 
product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">FDA</span>.</li><li><strong><a id="treatment-ind" tabindex="-1"></a>Treatment IND/Protocol</strong>: Allows a large, widespread population access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">FDA</span>.
 This type of expanded access can only be provided if the product is 
already being developed for marketing for the same use as the expanded 
access use.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-32" aria-expanded="false">Experimental arm</button><div class="glossary__definition" id="glossary-content-32" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" title="Show definition" tabindex="-1">arm type</span> in which a group of participants receives the <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> that is the focus of the clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-33" aria-expanded="false">Extension request</button><div class="glossary__definition" id="glossary-content-33" aria-hidden="true" style="display: none;">In
 certain circumstances, a sponsor or investigator may request an 
extension to delay the standard results submission deadline (generally 
one year after the <span class="term" data-term="primary completion date" title="Show definition" tabindex="-1">primary completion date</span>).
 The request for an extension must demonstrate good cause (for example, 
the need to preserve the scientific integrity of an ongoing <span class="term" data-term="masking" title="Show definition" tabindex="-1">masked</span>
 trial). All requests must be reviewed and granted by the National 
Institutes of Health. This process for review and granting of extension 
requests is being developed. See <a href="https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType" style="text-decoration:underline dotted" target="_blank" tabindex="-1">Delay Results Type</a> in the Results Data Element definitions for more information.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-34" aria-expanded="false">Factorial assignment</button><div class="glossary__definition" id="glossary-content-34" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" title="Show definition" tabindex="-1">intervention model</span>
 describing a clinical trial in which groups of participants receive one
 of several combinations of interventions. For example, two-by-two 
factorial assignment involves four groups of participants. Each group 
receives one of the following pairs of interventions: (1) drug A and 
drug B, (2) drug A and a placebo, (3) a placebo and drug B, or (4) a 
placebo and a placebo. So during the trial, all possible combinations of
 the two drugs (A and B) and the placebos are given to different groups 
of participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-35" aria-expanded="false">First posted</button><div class="glossary__definition" id="glossary-content-35" aria-hidden="true" style="display: none;">The date on which the <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>
 was first available on ClinicalTrials.gov. There is typically a delay 
of a few days between the date the study sponsor or investigator 
submitted the study record and the first posted date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-36" aria-expanded="false">First submitted</button><div class="glossary__definition" id="glossary-content-36" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>
 to ClinicalTrials.gov. There is typically a delay of a few days between
 the first submitted date and the record's availability on 
ClinicalTrials.gov (the <span class="term" data-term="first posted" title="Show definition" tabindex="-1">first posted</span> date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-37" aria-expanded="false">First submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-37" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span>
 criteria. The sponsor or investigator may need to revise and submit a 
study record one or more times before NLM's QC review criteria are met. 
It is the responsibility of the sponsor or investigator to ensure that 
the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-38" aria-expanded="false">Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)</button><div class="glossary__definition" id="glossary-content-38" aria-hidden="true" style="display: none;">U.S.
 Public Law 110-85, which was enacted on September 27, 2007. Section 801
 of FDAAA amends Section 402 of the U.S. Public Health Service Act to 
expand ClinicalTrials.gov and create a clinical study <span class="term" data-term="results database" title="Show definition" tabindex="-1">results database</span>. For more information on FDAAA 801, see the <a href="https://clinicaltrials.gov/ct2/about-site/history" style="text-decoration:underline dotted" target="_blank" tabindex="-1">History, Policies, and Laws</a> page on this site.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-39" aria-expanded="false">Funder type</button><div class="glossary__definition" id="glossary-content-39" aria-hidden="true" style="display: none;">Describes
 the organization that provides funding or support for a clinical study.
 This support may include activities related to funding, design, 
implementation, data analysis, or reporting. Organizations listed as <span class="term" data-term="sponsor" title="Show definition" tabindex="-1">sponsors</span> and <span class="term" data-term="collaborator" title="Show definition" tabindex="-1">collaborators</span> for a study are considered the funders of the study. ClinicalTrials.gov refers to four types of funders: <ul><li>U.S. National Institutes of Health</li><li>Other
 U.S. Federal agencies (for example, Food and Drug Administration, 
Centers for Disease Control and Prevention, or U.S. Department of 
Veterans Affairs)</li><li>Industry (for example: pharmaceutical and device companies)</li><li>All others (including individuals, universities, and community-based organizations)</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-40" aria-expanded="false">Gender-based eligibility</button><div class="glossary__definition" id="glossary-content-40" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span>
 that indicates whether eligibility to participate in a clinical study 
is based a person's self-representation of gender identity or gender 
(yes, no). Gender is distinct from <span class="term" data-term="sex" title="Show definition" tabindex="-1">sex</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-41" aria-expanded="false">Group/cohort</button><div class="glossary__definition" id="glossary-content-41" aria-hidden="true" style="display: none;">A group or subgroup of participants in an <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational study</span> that is assessed for biomedical or health outcomes.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-42" aria-expanded="false">Human subjects protection review board</button><div class="glossary__definition" id="glossary-content-42" aria-hidden="true" style="display: none;">A group of people who review, approve, and monitor the clinical study's <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>.
 Their role is to protect the rights and welfare of people participating
 in a study (referred to as human research subjects), such as reviewing 
the <span class="term" data-term="informed consent form (icf)" title="Show definition" tabindex="-1">informed consent form</span>.
 The group typically includes people with varying backgrounds, including
 a community member, to make sure that research activities conducted by 
an organization are completely and adequately reviewed. Also called an 
institutional review board, or IRB, or an ethics committee.<p>For more information, see <a href="https://clinicaltrials.gov/ct2/about-studies/learn#Participating" style="text-decoration:underline dotted" target="_blank" tabindex="-1">Participating in Studies</a> on this site.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-43" aria-expanded="false">Inclusion criteria</button><div class="glossary__definition" id="glossary-content-43" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span>. These are the reasons that a person is allowed to participate in a clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-44" aria-expanded="false">Informed consent</button><div class="glossary__definition" id="glossary-content-44" aria-hidden="true" style="display: none;">A
 process used by researchers to communicate to potential and enrolled 
participants the risks and potential benefits of participating in a 
clinical study. <p>For more information, see <a href="https://clinicaltrials.gov/ct2/about-studies/learn#Participating" style="text-decoration:underline dotted" target="_blank" tabindex="-1">Participating in Studies</a> on this site.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-45" aria-expanded="false">Informed consent form (ICF)</button><div class="glossary__definition" id="glossary-content-45" aria-hidden="true" style="display: none;">The document used in the <span class="term" data-term="informed consent" title="Show definition" tabindex="-1">informed consent</span> or process.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-46" aria-expanded="false">Intervention model</button><div class="glossary__definition" id="glossary-content-46" aria-hidden="true" style="display: none;">The
 general design of the strategy for assigning interventions to 
participants in a clinical study. Types of intervention models include: <span class="term" data-term="single group assignment" title="Show definition" tabindex="-1">single group assignment</span>, <span class="term" data-term="parallel assignment" title="Show definition" tabindex="-1">parallel assignment</span>, <span class="term" data-term="cross-over assignment" title="Show definition" tabindex="-1">cross-over assignment</span>, and <span class="term" data-term="factorial assignment" title="Show definition" tabindex="-1">factorial assignment</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-47" aria-expanded="false">Intervention/treatment</button><div class="glossary__definition" id="glossary-content-47" aria-hidden="true" style="display: none;">A
 process or action that is the focus of a clinical study. Interventions 
include drugs, medical devices, procedures, vaccines, and other products
 that are either investigational or already available. Interventions can
 also include noninvasive approaches, such as education or modifying 
diet and exercise.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-48" aria-expanded="false">Interventional study (clinical trial)</button><div class="glossary__definition" id="glossary-content-48" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="clinical study" title="Show definition" tabindex="-1">clinical study</span> in which participants are assigned to groups that receive one or more <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span>
 (or no intervention) so that researchers can evaluate the effects of 
the interventions on biomedical or health-related outcomes. The 
assignments are determined by the study's <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>. Participants may receive diagnostic, therapeutic, or other types of interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-49" aria-expanded="false">Investigator</button><div class="glossary__definition" id="glossary-content-49" aria-hidden="true" style="display: none;">A
 researcher involved in a clinical study. Related terms include site 
principal investigator, site sub-investigator, study chair, study 
director, and study <span class="term" data-term="principal investigator (pi)" title="Show definition" tabindex="-1">principal investigator</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-50" aria-expanded="false">Last update posted</button><div class="glossary__definition" id="glossary-content-50" aria-hidden="true" style="display: none;">The most recent date on which changes to a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>
 were made available on ClinicalTrials.gov. There may be a delay between
 when the changes were submitted to ClinicalTrials.gov by the study's 
sponsor or investigator (the <span class="term" data-term="last update submitted" title="Show definition" tabindex="-1">last update submitted</span> date) and the last update posted date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-51" aria-expanded="false">Last update submitted</button><div class="glossary__definition" id="glossary-content-51" aria-hidden="true" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>
 to ClinicalTrials.gov. There is typically a delay of a few days between
 the last update submitted date and when the date changes are posted on 
ClinicalTrials.gov (the <span class="term" data-term="last update posted" title="Show definition" tabindex="-1">last update posted</span> date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-52" aria-expanded="false">Last update submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-52" aria-hidden="true" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> that are consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span>
 criteria. It is the responsibility of the sponsor or investigator to 
ensure that the study record is consistent with the NLM QC review 
criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-53" aria-expanded="false">Last verified</button><div class="glossary__definition" id="glossary-content-53" aria-hidden="true" style="display: none;">The
 most recent date on which the study sponsor or investigator confirmed 
the information about a clinical study on ClinicalTrials.gov as accurate
 and current. If a study with a <span class="term" data-term="recruitment status" title="Show definition" tabindex="-1">recruitment status</span> of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's <span class="term" data-term="recruitment status" title="Show definition" tabindex="-1">recruitment status</span> is shown as <span class="term" data-term="unknown" title="Show definition" tabindex="-1">unknown</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-54" aria-expanded="false">Listed location countries</button><div class="glossary__definition" id="glossary-content-54" aria-hidden="true" style="display: none;">Countries
 in which research facilities for a study are located. A country is 
listed only once, even if there is more than one facility in the 
country. The list includes all countries as of the <span class="term" data-term="last update submitted" title="Show definition" tabindex="-1">last update submitted</span> date; any country for which all facilities were removed from the <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> are listed under <span class="term" data-term="removed location countries" title="Show definition" tabindex="-1">removed location countries</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-55" aria-expanded="false">Location terms</button><div class="glossary__definition" id="glossary-content-55" aria-hidden="true" style="display: none;">In
 the search feature, the Location terms field is used to narrow a search
 by location-related terms other than Country, State, and City or 
distance. For example, you may enter a specific facility name (such as 
National Institutes of Health Clinical Center) or a part of a facility 
name (such as Veteran for studies listing Veterans Hospital or Veteran 
Affairs in the facility name). Note: Not all <span class="term" data-term="study record" title="Show definition" tabindex="-1">study records</span> include this level of detail about locations.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-56" aria-expanded="false">Masking</button><div class="glossary__definition" id="glossary-content-56" aria-hidden="true" style="display: none;">A
 clinical trial design strategy in which one or more parties involved in
 the trial, such as the investigator or participants, do not know which 
participants have been assigned which interventions. Types of masking 
include: open label, single blind masking, and double-blind masking.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-57" aria-expanded="false">NCT number</button><div class="glossary__definition" id="glossary-content-57" aria-hidden="true" style="display: none;">A
 unique identification code given to each clinical study record 
registered on ClinicalTrials.gov. The format is "NCT" followed by an 
8-digit number (for example, NCT00000419). Also called the <span class="term" data-term="clinicaltrials.gov identifier (nct number)" title="Show definition" tabindex="-1">ClinicalTrials.gov identifier</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-58" aria-expanded="false">No intervention arm</button><div class="glossary__definition" id="glossary-content-58" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" title="Show definition" tabindex="-1">arm type</span> in which a group of participants does not receive any <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> during the clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-59" aria-expanded="false">Observational study</button><div class="glossary__definition" id="glossary-content-59" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="clinical study" title="Show definition" tabindex="-1">clinical study</span>
 in which participants are identified as belonging to study groups and 
are assessed for biomedical or health outcomes. Participants may receive
 diagnostic, therapeutic, or other types of interventions, but the 
investigator does not assign participants to a specific <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">interventions/treatment</span>.<p>A <span class="term" data-term="patient registry" title="Show definition" tabindex="-1">patient registry</span> is a type of observational study.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-60" aria-expanded="false">Observational study model</button><div class="glossary__definition" id="glossary-content-60" aria-hidden="true" style="display: none;">The general design of the strategy for identifying and following up with participants during an <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational study</span>.
 Types of observational study models include cohort, case-control, 
case-only, case-cross-over, ecologic or community studies, family-based,
 and other.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-61" aria-expanded="false">Other adverse event</button><div class="glossary__definition" id="glossary-content-61" aria-hidden="true" style="display: none;">An <span class="term" data-term="adverse event" title="Show definition" tabindex="-1">adverse event</span> that is not a <span class="term" data-term="serious adverse event" title="Show definition" tabindex="-1">serious adverse event</span>,
 meaning that it does not result in death, is not life-threatening, does
 not require inpatient hospitalization or extend a current hospital 
stay, does not result in an ongoing or significant incapacity or 
interfere substantially with normal life functions, and does not cause a
 congenital anomaly or birth defect; it also does not put the 
participant in danger and does not require medical or surgical 
intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-62" aria-expanded="false">Other study IDs</button><div class="glossary__definition" id="glossary-content-62" aria-hidden="true" style="display: none;">Identifiers or ID numbers other than the <span class="term" data-term="nct number" title="Show definition" tabindex="-1">NCT number</span>
 that are assigned to a clinical study by the study's sponsor, funders, 
or others. These numbers may include unique identifiers from other trial
 registries and National Institutes of Health grant numbers.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-63" aria-expanded="false">Other terms</button><div class="glossary__definition" id="glossary-content-63" aria-hidden="true" style="display: none;">In
 the search feature, the Other terms field is used to narrow a search. 
For example, you may enter the name of a drug or the NCT number of a 
clinical study to limit the search to <span class="term" data-term="study record" title="Show definition" tabindex="-1">study records</span> that contain these words.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-64" aria-expanded="false">Outcome measure</button><div class="glossary__definition" id="glossary-content-64" aria-hidden="true" style="display: none;">For <span class="term" data-term="clinical trial" title="Show definition" tabindex="-1">clinical trials</span>, a planned measurement described in the protocol that is used to determine the effect of an <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> on participants. For <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational studies</span>,
 a measurement or observation that is used to describe patterns of 
diseases or traits, or associations with exposures, risk factors, or 
treatment. Types of outcome measures include <span class="term" data-term="primary outcome measure" title="Show definition" tabindex="-1">primary outcome measure</span> and <span class="term" data-term="secondary outcome measure" title="Show definition" tabindex="-1">secondary outcome measure</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-65" aria-expanded="false">Parallel assignment</button><div class="glossary__definition" id="glossary-content-65" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" title="Show definition" tabindex="-1">intervention model</span>
 describing a clinical trial in which two or more groups of participants
 receive different interventions. For example, a two-arm parallel 
assignment involves two groups of participants. One group receives drug 
A, and the other group receives drug B. So during the trial, 
participants in one group receive drug A "in parallel" to participants 
in the other group, who receive drug B.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-66" aria-expanded="false">Participant flow</button><div class="glossary__definition" id="glossary-content-66" aria-hidden="true" style="display: none;">A summary of the progress of participants through each stage of a clinical study, by study <span class="term" data-term="arm" title="Show definition" tabindex="-1">arm</span> or <span class="term" data-term="group/cohort" title="Show definition" tabindex="-1">group/cohort</span>. This includes the number of participants who started, completed, and dropped out of the study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-67" aria-expanded="false">Patient registry</button><div class="glossary__definition" id="glossary-content-67" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational study</span>
 that collects information about patients' medical conditions and/or 
treatments to better understand how a condition or treatment affects 
patients in the real world.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-68" aria-expanded="false">Phase</button><div class="glossary__definition" id="glossary-content-68" aria-hidden="true" style="display: none;">The stage of a clinical trial studying a drug or biological product, based on definitions developed by the <span class="term" data-term="u.s. food and drug administration (fda)" title="Show definition" tabindex="-1">U.S. Food and Drug Administration (FDA)</span>. The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: <span class="term" data-term="early phase 1 (formerly listed as phase 0)" title="Show definition" tabindex="-1">Early Phase 1 (formerly listed as Phase 0)</span>, <span class="term" data-term="phase 1" title="Show definition" tabindex="-1">Phase 1</span>, <span class="term" data-term="phase 2" title="Show definition" tabindex="-1">Phase 2</span>, <span class="term" data-term="phase 3" title="Show definition" tabindex="-1">Phase 3</span>, and <span class="term" data-term="phase 4" title="Show definition" tabindex="-1">Phase 4</span>. <span class="term" data-term="phase not applicable" title="Show definition" tabindex="-1">Not Applicable</span> is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-69" aria-expanded="false">Phase 1</button><div class="glossary__definition" id="glossary-content-69" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" title="Show definition" tabindex="-1">phase</span>
 of research to describe clinical trials that focus on the safety of a 
drug. They are usually conducted with healthy volunteers, and the goal 
is to determine the drug's most frequent and <span class="term" data-term="serious adverse event" title="Show definition" tabindex="-1">serious adverse events</span> and, often, how the drug is broken down and excreted by the body. These trials usually involve a small number of participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-70" aria-expanded="false">Phase 2</button><div class="glossary__definition" id="glossary-content-70" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" title="Show definition" tabindex="-1">phase</span> of research to describe clinical trials that gather preliminary data on whether a drug works in people who have a certain <span class="term" data-term="condition/disease" title="Show definition" tabindex="-1">condition/disease</span>
 (that is, the drug's effectiveness). For example, participants 
receiving the drug may be compared to similar participants receiving a 
different treatment, usually an inactive substance (called a <span class="term" data-term="placebo" title="Show definition" tabindex="-1">placebo</span>) or a different drug. Safety continues to be evaluated, and short-term <span class="term" data-term="adverse event" title="Show definition" tabindex="-1">adverse events</span> are studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-71" aria-expanded="false">Phase 3</button><div class="glossary__definition" id="glossary-content-71" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" title="Show definition" tabindex="-1">phase</span>
 of research to describe clinical trials that gather more information 
about a drug's safety and effectiveness by studying different 
populations and different dosages and by using the drug in combination 
with other drugs. These studies typically involve more participants.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-72" aria-expanded="false">Phase 4</button><div class="glossary__definition" id="glossary-content-72" aria-hidden="true" style="display: none;">A <span class="term" data-term="phase" title="Show definition" tabindex="-1">phase</span>
 of research to describe clinical trials occurring after FDA has 
approved a drug for marketing. They include postmarket requirement and 
commitment studies that are required of or agreed to by the study 
sponsor. These trials gather additional information about a drug's 
safety, efficacy, or optimal use.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-73" aria-expanded="false">Phase Not Applicable</button><div class="glossary__definition" id="glossary-content-73" aria-hidden="true" style="display: none;">Describes trials without FDA-defined <span class="term" data-term="phase" title="Show definition" tabindex="-1">phases</span>, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-74" aria-expanded="false">Placebo</button><div class="glossary__definition" id="glossary-content-74" aria-hidden="true" style="display: none;">An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-75" aria-expanded="false">Placebo comparator arm</button><div class="glossary__definition" id="glossary-content-75" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" title="Show definition" tabindex="-1">arm type</span> in which a group of participants receives a <span class="term" data-term="placebo" title="Show definition" tabindex="-1">placebo</span> during a clinical trial.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-76" aria-expanded="false">Primary completion date</button><div class="glossary__definition" id="glossary-content-76" aria-hidden="true" style="display: none;">The
 date on which the last participant in a clinical study was examined or 
received an intervention to collect final data for the <span class="term" data-term="primary outcome measure" title="Show definition" tabindex="-1">primary outcome measure</span>. Whether the clinical study ended according to the <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>
 or was terminated does not affect this date. For clinical studies with 
more than one primary outcome measure with different completion dates, 
this term refers to the date on which data collection is completed for 
all the primary outcome measures. The "estimated" primary completion 
date is the date that the researchers think will be the primary 
completion date for the study. </div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-77" aria-expanded="false">Primary outcome measure</button><div class="glossary__definition" id="glossary-content-77" aria-hidden="true" style="display: none;">In a clinical study's <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>, the planned outcome measure that is the most important for evaluating the effect of an <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span>. Most clinical studies have one primary outcome measure, but some have more than one.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-78" aria-expanded="false">Primary purpose</button><div class="glossary__definition" id="glossary-content-78" aria-hidden="true" style="display: none;">The main reason for the <span class="term" data-term="clinical trial" title="Show definition" tabindex="-1">clinical trial</span>.
 The types of primary purpose are: treatment, prevention, diagnostic, 
supportive care, screening, health services research, basic science, and
 other.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-79" aria-expanded="false">Principal investigator (PI)</button><div class="glossary__definition" id="glossary-content-79" aria-hidden="true" style="display: none;">The person who is responsible for the scientific and technical direction of the entire clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-80" aria-expanded="false">Protocol</button><div class="glossary__definition" id="glossary-content-80" aria-hidden="true" style="display: none;">The
 written description of a clinical study. It includes the study's 
objectives, design, and methods. It may also include relevant scientific
 background and statistical information.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-81" aria-expanded="false">Quality control (QC) review</button><div class="glossary__definition" id="glossary-content-81" aria-hidden="true" style="display: none;">National Library of Medicine (NLM) staff perform a limited review of submitted <span class="term" data-term="study record" title="Show definition" tabindex="-1">study records</span>
 for apparent errors, deficiencies, or inconsistencies. NLM staff 
identify potential major and advisory issues and provide comments 
directly to the study sponsor or investigator. Major issues identified 
in QC review must be addressed or corrected (see <span class="term" data-term="first submitted that met qc criteria" title="Show definition" tabindex="-1">First submitted that met QC criteria</span> and <span class="term" data-term="results first submitted that met qc criteria" title="Show definition" tabindex="-1">Results first submitted that met QC criteria</span>).
 Advisory issues are suggestions to help improve the clarity of the 
record. NLM staff do not verify the scientific validity or relevance of 
the submitted information. The study sponsor or investigator is 
responsible for ensuring that the studies follow all applicable laws and
 regulations.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-82" aria-expanded="false">Randomized allocation</button><div class="glossary__definition" id="glossary-content-82" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="allocation" title="Show definition" tabindex="-1">allocation</span> strategy in which participants are assigned to the <span class="term" data-term="arm" title="Show definition" tabindex="-1">arms</span> of a clinical trial by chance.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-83" aria-expanded="false">Recruitment status</button><div class="glossary__definition" id="glossary-content-83" aria-hidden="true" style="display: none;"><ul><li><strong>Not yet recruiting:</strong> The study has not started recruiting participants.</li><li><strong>Recruiting:</strong> The study is currently recruiting participants.</li><li><strong>Enrolling by invitation:</strong>
 The study is selecting its participants from a population, or group of 
people, decided on by the researchers in advance. These studies are not 
open to everyone who meets the eligibility criteria but only to people 
in that particular population, who are specifically invited to 
participate.</li><li><strong>Active, not recruiting:</strong> The study 
is ongoing, and participants are receiving an intervention or being 
examined, but potential participants are not currently being recruited 
or enrolled.</li><li><strong>Suspended:</strong> The study has stopped early but may start again.</li><li><strong>Terminated:</strong> The study has stopped early and will not start again. Participants are no longer being examined or treated.</li><li><strong>Completed:</strong>
 The study has ended normally, and participants are no longer being 
examined or treated (that is, the last participant's last visit has 
occurred).</li><li><strong>Withdrawn:</strong> The study stopped early, before enrolling its first participant.</li><li><strong>Unknown:</strong>
 A study on ClinicalTrials.gov whose last known status was recruiting; 
not yet recruiting; or active, not recruiting but that has passed its 
completion date, and the status has not been <span class="term" data-term="last verified" title="Show definition" tabindex="-1">last verified</span> within the past 2 years.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-84" aria-expanded="false">Registration</button><div class="glossary__definition" id="glossary-content-84" aria-hidden="true" style="display: none;">The process of submitting and updating summary information about a clinical study and its <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>, from its beginning to end, to a structured, public Web-based <span class="term" data-term="study registry" title="Show definition" tabindex="-1">study registry</span> that is accessible to the public, such as ClinicalTrials.gov.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-85" aria-expanded="false">Removed location countries</button><div class="glossary__definition" id="glossary-content-85" aria-hidden="true" style="display: none;">Countries that appeared under <span class="term" data-term="listed location countries" title="Show definition" tabindex="-1">listed location countries</span> but were removed from the <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> by the sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-86" aria-expanded="false">Reporting group</button><div class="glossary__definition" id="glossary-content-86" aria-hidden="true" style="display: none;">A
 grouping of participants in a clinical study that is used for 
summarizing the data collected during the study. This grouping may be 
the same as or different from a study arm or group.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-87" aria-expanded="false">Responsible party</button><div class="glossary__definition" id="glossary-content-87" aria-hidden="true" style="display: none;">The
 person responsible for submitting information about a clinical study to
 ClinicalTrials.gov and updating that information. Usually the study 
sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-88" aria-expanded="false">Results database</button><div class="glossary__definition" id="glossary-content-88" aria-hidden="true" style="display: none;">A
 structured online system, such as the ClinicalTrials.gov results 
database, that provides the public with access to registration and 
summary results information for completed or terminated clinical 
studies. A study with results available on ClinicalTrials.gov is 
described as having the results "posted." <p><strong>Note:</strong> The 
ClinicalTrials.gov results database became available in September 2008. 
Older studies are unlikely to have results available in the database.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-89" aria-expanded="false">Results delayed</button><div class="glossary__definition" id="glossary-content-89" aria-hidden="true" style="display: none;">Indicates that the sponsor or investigator submitted a <span class="term" data-term="certification" title="Show definition" tabindex="-1">certification</span> or <span class="term" data-term="extension request" title="Show definition" tabindex="-1">extension request</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-90" aria-expanded="false">Results first posted</button><div class="glossary__definition" id="glossary-content-90" aria-hidden="true" style="display: none;">The
 date on which summary results information was first available on 
ClinicalTrials.gov. There is typically a delay between the date the 
study sponsor or investigator first submits summary results information 
(the <span class="term" data-term="results first submitted" title="Show definition" tabindex="-1">results first submitted</span> date) and the results first posted date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-91" aria-expanded="false">Results first submitted</button><div class="glossary__definition" id="glossary-content-91" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>
 with summary results information. There is typically a delay between 
the results first submitted date and when summary results information 
becomes available on ClinicalTrials.gov (the <span class="term" data-term="results first posted" title="Show definition" tabindex="-1">results first posted</span> date).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-92" aria-expanded="false">Results first submitted that met QC criteria</button><div class="glossary__definition" id="glossary-content-92" aria-hidden="true" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> with summary results information that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span>
 criteria. The sponsor or investigator may need to revise and submit 
results information one or more times before NLM's QC review criteria 
are met. It is the responsibility of the sponsor or investigator to 
ensure that the study record is consistent with the NLM QC review 
criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-93" aria-expanded="false">Results returned after quality control review</button><div class="glossary__definition" id="glossary-content-93" aria-hidden="true" style="display: none;">The date on which the National Library of Medicine provided <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span>
 comments to the study sponsor or investigator. The sponsor or 
investigator must address major issues identified in the review 
comments. If there is a date listed for results returned after quality 
control review, but there is not a subsequent date listed for <span class="term" data-term="results submitted to clinicaltrials.gov" title="Show definition" tabindex="-1">results submitted to ClinicalTrials.gov</span>, this means that the submission is pending changes by the sponsor or investigator.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-94" aria-expanded="false">Results submitted to ClinicalTrials.gov</button><div class="glossary__definition" id="glossary-content-94" aria-hidden="true" style="display: none;">Indicates
 that the study sponsor or investigator has submitted summary results 
information for a clinical study to ClinicalTrials.gov but the <span class="term" data-term="quality control (qc) review" title="Show definition" tabindex="-1">quality control (QC) review</span> process has not concluded.<p>The
 results submitted date indicates when the study sponsor or investigator
 first submitted summary results information or submitted changes to 
summary results information. Submissions with changes are typically in 
response to  QC review comments from the National Library of Medicine 
(NLM). If there is a date listed for results submitted to 
ClinicalTrials.gov, but there is not a subsequent date listed for <span class="term" data-term="results returned after quality control review" title="Show definition" tabindex="-1">results returned after quality control review</span>, this means that the submission is pending review by NLM.</p></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-95" aria-expanded="false">Secondary outcome measure</button><div class="glossary__definition" id="glossary-content-95" aria-hidden="true" style="display: none;">In a clinical study's <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>,
 a planned outcome measure that is not as important as the primary 
outcome measure for evaluating the effect of an intervention but is 
still of interest. Most clinical studies have more than one secondary 
outcome measure.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-96" aria-expanded="false">Serious adverse event</button><div class="glossary__definition" id="glossary-content-96" aria-hidden="true" style="display: none;">An <span class="term" data-term="adverse event" title="Show definition" tabindex="-1">adverse event</span>
 that results in death, is life-threatening, requires inpatient 
hospitalization or extends a current hospital stay, results in an 
ongoing or significant incapacity or interferes substantially with 
normal life functions, or causes a congenital anomaly or birth defect. 
Medical events that do not result in death, are not life-threatening, or
 do not require hospitalization may be considered serious adverse events
 if they put the participant in danger or require medical or surgical 
intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-97" aria-expanded="false">Sex</button><div class="glossary__definition" id="glossary-content-97" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="eligibility criteria" title="Show definition" tabindex="-1">eligibility criteria</span>
 that indicates the sex of people who may participate in a clinical 
study (all, female, male). Sex is a person's classification as female or
 male based on biological distinctions. Sex is distinct from <span class="term" data-term="gender-based eligibility" title="Show definition" tabindex="-1">gender-based eligibility</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-98" aria-expanded="false">Sham comparator arm</button><div class="glossary__definition" id="glossary-content-98" aria-hidden="true" style="display: none;">An <span class="term" data-term="arm type" title="Show definition" tabindex="-1">arm type</span>
 in which a group of participants receives a procedure or device that 
appears to be the same as the actual procedure or device being studied 
but does not contain active processes or components.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-99" aria-expanded="false">Single group assignment</button><div class="glossary__definition" id="glossary-content-99" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="intervention model" title="Show definition" tabindex="-1">intervention model</span> describing a clinical trial in which all participants receive the same intervention/treatment.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-100" aria-expanded="false">Sort studies by</button><div class="glossary__definition" id="glossary-content-100" aria-hidden="true" style="display: none;">In
 Advanced Search, the Sort studies by option is used to change the order
 of studies listed on the Search Results page. You can sort by Relevance
 or Newest First: <ul><li>Relevance: Studies that best match your search
 terms appear higher in the search results list. This is the default 
display for all searches.</li><li>Newest First: Studies with the most recent <span class="term" data-term="first posted" title="Show definition" tabindex="-1">First posted</span> dates appear higher in the search results list.</li></ul></div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-101" aria-expanded="false">Sponsor</button><div class="glossary__definition" id="glossary-content-101" aria-hidden="true" style="display: none;">The organization or person who initiates the study and who has authority and control over the study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-102" aria-expanded="false">State</button><div class="glossary__definition" id="glossary-content-102" aria-hidden="true" style="display: none;">In
 the search feature, the State field is used to find clinical studies 
with locations in a specific state within the United States. If you 
choose United States in the <span class="term" data-term="country" title="Show definition" tabindex="-1">Country</span> field, you can search for studies with locations in a specific state.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-103" aria-expanded="false">Statistical analysis plan (SAP)</button><div class="glossary__definition" id="glossary-content-103" aria-hidden="true" style="display: none;">The written description of the statistical considerations and methods for analyzing the data collected in the <span class="term" data-term="clinical study" title="Show definition" tabindex="-1">clinical study</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-104" aria-expanded="false">Status</button><div class="glossary__definition" id="glossary-content-104" aria-hidden="true" style="display: none;">Indicates the current <span class="term" data-term="recruitment status" title="Show definition" tabindex="-1">recruitment status</span> or the <span class="term" data-term="expanded access status" title="Show definition" tabindex="-1">expanded access status</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-105" aria-expanded="false">Study completion date</button><div class="glossary__definition" id="glossary-content-105" aria-hidden="true" style="display: none;">The date on which the last participant in a clinical study was examined or received an <span class="term" data-term="intervention/treatment" title="Show definition" tabindex="-1">intervention/treatment</span> to collect final data for the <span class="term" data-term="primary outcome measure" title="Show definition" tabindex="-1">primary outcome measures</span>, <span class="term" data-term="secondary outcome measure" title="Show definition" tabindex="-1">secondary outcome measures</span>, and <span class="term" data-term="adverse event" title="Show definition" tabindex="-1">adverse events</span>
 (that is, the last participant's last visit). The "estimated" study 
completion date is the date that the researchers think will be the study
 completion date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-106" aria-expanded="false">Study design</button><div class="glossary__definition" id="glossary-content-106" aria-hidden="true" style="display: none;">The investigative methods and strategies used in the clinical study.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-107" aria-expanded="false">Study documents</button><div class="glossary__definition" id="glossary-content-107" aria-hidden="true" style="display: none;">Refers to the type of documents that the study sponsor or principal investigator may add to their <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span>. These include a study <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span>, <span class="term" data-term="statistical analysis plan (sap)" title="Show definition" tabindex="-1">statistical analysis plan</span>, and <span class="term" data-term="informed consent form (icf)" title="Show definition" tabindex="-1">informed consent form</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-108" aria-expanded="false">Study IDs</button><div class="glossary__definition" id="glossary-content-108" aria-hidden="true" style="display: none;">Identifiers that are assigned to a clinical study by the study's <span class="term" data-term="sponsor" title="Show definition" tabindex="-1">sponsor</span>, funders, or others. They include unique identifiers from other trial <span class="term" data-term="study registry" title="Show definition" tabindex="-1">study registries</span>
 and National Institutes of Health grant numbers. Note: 
ClinicalTrials.gov assigns a unique identification code to each clinical
 study registered on ClinicalTrials.gov. Also called the <span class="term" data-term="nct number" title="Show definition" tabindex="-1">NCT number</span>, the format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-109" aria-expanded="false">Study record</button><div class="glossary__definition" id="glossary-content-109" aria-hidden="true" style="display: none;">An entry on ClinicalTrials.gov that contains a summary of a clinical study's protocol information, including the <span class="term" data-term="recruitment status" title="Show definition" tabindex="-1">recruitment status</span>;
 eligibility criteria; contact information; and, in some cases, summary 
results. Each study record is assigned a ClinicalTrials.gov identifier, 
or <span class="term" data-term="nct number" title="Show definition" tabindex="-1">NCT number</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-110" aria-expanded="false">Study registry</button><div class="glossary__definition" id="glossary-content-110" aria-hidden="true" style="display: none;">A
 structured online system, such as ClinicalTrials.gov, that provides the
 public with access to summary information about ongoing and completed 
clinical studies.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-111" aria-expanded="false">Study results</button><div class="glossary__definition" id="glossary-content-111" aria-hidden="true" style="display: none;">A <span class="term" data-term="study record" title="Show definition" tabindex="-1">study record</span> that includes the summary results posted in the ClinicalTrials.gov <span class="term" data-term="results database" title="Show definition" tabindex="-1">results database</span>. Summary results information includes <span class="term" data-term="participant flow" title="Show definition" tabindex="-1">participant flow</span>, <span class="term" data-term="baseline characteristics" title="Show definition" tabindex="-1">baseline characteristics</span>, <span class="term" data-term="outcome measure" title="Show definition" tabindex="-1">outcome measures</span>, and <span class="term" data-term="adverse event" title="Show definition" tabindex="-1">adverse events</span> (including <span class="term" data-term="serious adverse event" title="Show definition" tabindex="-1">serious adverse events</span>).</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-112" aria-expanded="false">Study start date</button><div class="glossary__definition" id="glossary-content-112" aria-hidden="true" style="display: none;">The
 actual date on which the first participant was enrolled in a clinical 
study. The "estimated" study start date is the date that the researchers
 think will be the study start date.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-113" aria-expanded="false">Study type</button><div class="glossary__definition" id="glossary-content-113" aria-hidden="true" style="display: none;">Describes the nature of a <span class="term" data-term="clinical study" title="Show definition" tabindex="-1">clinical study</span>. Study types include <span class="term" data-term="interventional study (clinical trial)" title="Show definition" tabindex="-1">interventional studies</span> (also called clinical trials), <span class="term" data-term="observational study" title="Show definition" tabindex="-1">observational studies</span> (including <span class="term" data-term="patient registry" title="Show definition" tabindex="-1">patient registries</span>), and <span class="term" data-term="expanded access" title="Show definition" tabindex="-1">expanded access</span>.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-114" aria-expanded="false">Submitted date</button><div class="glossary__definition" id="glossary-content-114" aria-hidden="true" style="display: none;">The
 date on which the study sponsor or investigator submitted a study 
record that is consistent with National Library of Medicine (NLM) 
quality control (QC) review criteria.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-115" aria-expanded="false">Title</button><div class="glossary__definition" id="glossary-content-115" aria-hidden="true" style="display: none;">The official title of a <span class="term" data-term="protocol" title="Show definition" tabindex="-1">protocol</span> used to identify a clinical study or a short title written in language intended for the lay public.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-116" aria-expanded="false">Title acronym</button><div class="glossary__definition" id="glossary-content-116" aria-hidden="true" style="display: none;">The
 acronym or initials used to identify a clinical study (not all studies 
have one). For example, the title acronym for the Women's Health 
Initiative is "WHI."</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-117" aria-expanded="false">U.S. Agency for Healthcare Research and Quality (AHRQ)</button><div class="glossary__definition" id="glossary-content-117" aria-hidden="true" style="display: none;">An
 agency within the U.S. Department of Health and Human Services. AHRQ's 
mission is to produce evidence to make health care safer, higher 
quality, more accessible, equitable, and affordable, and to work within 
the U.S. Department of Health and Human Services and with other partners
 to make sure that the evidence is understood and used.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-118" aria-expanded="false">U.S. Food and Drug Administration (FDA)</button><div class="glossary__definition" id="glossary-content-118" aria-hidden="true" style="display: none;">An
 agency within the U.S. Department of Health and Human Services. The FDA
 is responsible for protecting the public health by making sure that 
human and veterinary drugs, vaccines and other biological products, 
medical devices, the Nation's food supply, cosmetics, dietary 
supplements, and products that give off radiation are safe, effective, 
and secure.</div></li><li class="glossary__item"><button class="data-glossary-term glossary__term" tabindex="-1" aria-controls="glossary-content-119" aria-expanded="false">Unknown</button><div class="glossary__definition" id="glossary-content-119" aria-hidden="true" style="display: none;">A type of <span class="term" data-term="recruitment status" title="Show definition" tabindex="-1">recruitment status</span>.
 It identifies a study on ClinicalTrials.gov whose last known status was
 recruiting; not yet recruiting; or active, not recruiting but that has 
passed its completion date, and the status has not been verified within 
the past 2 years. Studies with an unknown status are considered closed 
studies.</div></li></ul>
  </div>
</div>

<div id="skip"> <a href="#main-content">Skip to Main Content</a> </div>


<div id="workingDim" class="ct-dim">
  <div id="workingIndicator" class="ct-workingBox" style="text-align:center;vertical-align:middle;">
    <img alt="Working" src="reportedlate_cancelledresubmitted_same_day_files/working.gif" height="50">
  </div>
</div>

<script type="text/javascript" async="" src="reportedlate_cancelledresubmitted_same_day_files/working.js"></script><noscript></noscript>


<div class="w3-container w3-center" style="padding:0.1ex 0.125in 0;background:#205493;color:white;margin-top:4px;">
    <div style="display:inline-block;">Help guide our efforts to <a style="color:white;border-bottom:1px solid white;" href="https://clinicaltrials.gov/ct2/about-site/modernization">modernize ClinicalTrials.gov</a>.</div>
    <div style="display:inline-block;margin-left:0.5em;">Send us your <a style="color:white;border-bottom:1px solid white;" title="Send us your comments - opens new window" href="https://grants.nih.gov/grants/guide/notice-files/NOT-LM-20-003.html" onclick="openNewWindow('https://grants.nih.gov/grants/guide/notice-files/NOT-LM-20-003.html'); return false">comments</a> by March 14, 2020.</div>
</div>

<div id="wrapper"> 
<div class="ct-inner_wrapper">   			<a href="https://clinicaltrials.gov/ct2/home" style="float:left;border-bottom-width:0;min-width:200px;width:30%;"><img src="reportedlate_cancelledresubmitted_same_day_files/ct.png" alt="ClinicalTrials.gov"></a>

				<div id="hamburger" class="w3-hide-medium w3-hide-large" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;" title="Show menus">
			<img src="reportedlate_cancelledresubmitted_same_day_files/hamburgerMenuIcon.png" alt="ClinicalTrials.gov Menu" style="max-width:30px;cursor:pointer;" onclick="$('#global-nav-popupMenu').toggle();">
		</div>
		<div id="global-nav-popupMenu" class="w3-hide-medium w3-hide-large w3-modal w3-center" style="display:none;" onclick="$('#global-nav-popupMenu').hide();"> 			<div id="global-nav-popupMenu-content" class="w3-modal-content">
				<div class="w3-container">
				    <span onclick="$('#global-nav-popupMenu').hide();" class="w3-closebtn"></span>
					<ul class="sf-menu sf-vertical sf-js-enabled">
									<li class="first"><a href="https://clinicaltrials.gov/ct2/search/index" class="sf-with-ul">Find Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Find Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/home">New Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/map">See Studies on Map</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/help/how-find/index">How to Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-use-search-results">How to Use Search Results</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-read-study">How to Read a Study Record</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/about-studies" class="sf-with-ul">About Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="About Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/learn">Learn About Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/manage-recs" class="sf-with-ul">Submit Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Submit Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/fdaaa">FDAAA 801 and the Final Rule</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-register">How to Register Your Study</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/resources">Support Materials</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/present">Training Materials</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/resources" class="sf-with-ul">Resources<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Resources Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/resources/pubs">Selected Publications</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/resources/trends">Trends, Charts, and Maps</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/download">Downloading Content for Analysis</a></li>
			</ul>
			</li>
			<li class="last"><a href="https://clinicaltrials.gov/ct2/about-site" class="sf-with-ul">About Site<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="About Site Menu"></a>
			<ul style="display: none;">
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/new">What's New</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/results">About the Results Database</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/history">History, Policies, and Laws</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/modernization">ClinicalTrials.gov Modernization</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/for-media">Media/Press Resources</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/link-to">Linking to This Site</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
			</ul>
			</li>
					</ul>
				</div>
    		</div>
  		</div>		
		
<div style="float:right;margin-top:1.5%;" class="w3-hide-small">
	<ul class="sf-menu sf-vertical sf-js-enabled">
				<li class="first"><a href="https://clinicaltrials.gov/ct2/search/index" class="sf-with-ul">Find Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Find Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/home">New Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/search/map">See Studies on Map</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/help/how-find/index">How to Search</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-use-search-results">How to Use Search Results</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/help/how-read-study">How to Read a Study Record</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/about-studies" class="sf-with-ul">About Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="About Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/learn">Learn About Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/manage-recs" class="sf-with-ul">Submit Studies<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Submit Studies Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/fdaaa">FDAAA 801 and the Final Rule</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-register">How to Register Your Study</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/resources">Support Materials</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/manage-recs/present">Training Materials</a></li>
			</ul>
			</li>
			<li><a href="https://clinicaltrials.gov/ct2/resources" class="sf-with-ul">Resources<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="Resources Menu"></a>
			<ul style="display: none;">
                      <li><a href="https://clinicaltrials.gov/ct2/resources/pubs">Selected Publications</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/resources/trends">Trends, Charts, and Maps</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/resources/download">Downloading Content for Analysis</a></li>
			</ul>
			</li>
			<li class="last"><a href="https://clinicaltrials.gov/ct2/about-site" class="sf-with-ul">About Site<img src="reportedlate_cancelledresubmitted_same_day_files/pulldown.png" alt="About Site Menu"></a>
			<ul style="display: none;">
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/new">What's New</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/results">About the Results Database</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/history">History, Policies, and Laws</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/modernization">ClinicalTrials.gov Modernization</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/for-media">Media/Press Resources</a></li>
                      <li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/link-to">Linking to This Site</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
                      <li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
			</ul>
			</li>
	</ul>
    <div style="clear:both;"></div>
</div>
<div style="clear:both;"></div>

</div> 
<div class="ct-outer_breadcrumb w3-container">
	<div id="breadcrumb">
    <ul class="ct-horz-list w3-left">
			<li><a href="https://clinicaltrials.gov/ct2/home">Home</a></li>
												<li><a href="https://clinicaltrials.gov/ct2/results">Search Results</a></li>
										<li>Study Record Detail</li>
    </ul>
    <div id="savedStudies" class="w3-right">
  	<div id="cart" style="cursor: pointer; display: none;" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();">
  	<button class="ct-savedStudiesEnabled" id="open-cart-link" type="button" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();" title="Show previously saved studies.">Saved Studies (0)</button>
  	</div>
</div>
<script type="text/javascript" src="reportedlate_cancelledresubmitted_same_day_files/cart.js"></script><noscript></noscript>

		<script type="text/javascript">
	$(document).ready(function(){
		$("input#saved").prop( 'checked', (inCart("NCT01234532")>=0));
	});
</script>
		<div class="w3-right" style="margin-right: 1em;">
			<label for="saved" title="Add or Remove this study in the Saved Studies list"><input type="checkbox" id="saved" name="NCT01234532" onchange="updateCart('NCT01234532');" style="margin-left:1em;"> Save this study </label>
		</div>
		<div id="maxSavedStudies-popup" class="w3-modal" style="cursor:pointer;border:2px groove" onclick="$('#maxSavedStudies-popup').hide();">
	<div id="maxSavedStudies-popup-content" class="w3-modal-content">
		<div class="w3-display-container" style="border:1px solid #ccc;background-color:#eee;">
			<form>
			<div class="w3-center" style="font-size:large;font-weight:bold;padding:3ex 1.5em;">
				<img src="reportedlate_cancelledresubmitted_same_day_files/warning.png" alt="Maximum Saved Studies Reached" style="max-width:1.0rem;cursor:pointer;">
			    <b>Warning</b>
				<div style="margin-top:1ex;margin-bottom:0.5ex;">You have reached the maximum number of saved studies (100).</div>
				<div>Please remove one or more studies before adding more.</div>
			</div>
		
			<div class="w3-center" style="padding-bottom:1.5ex">
			  <input class="ct-searchButton" type="button" style="opacity:1.0;font-weight:bold;font-size:inherit;padding:1.1ex 1em;" onclick="$('#maxSavedStudies-popup').hide();" value="Close" title="Close this dialog">
			</div>
			</form>
		</div>
	</div>
</div>

	</div>
</div>

<div id="main-content">

<div class="tr-indent2">
        	<h1 class="tr-h1 ct-sans-serif tr-solo_record">Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery</h1>

  <div class="w3-row">
    <div class="w3-col m6">       <div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
        <table>
          <tbody><tr>
            <td style="width:5%">
              <img src="reportedlate_cancelledresubmitted_same_day_files/warning.png" style="width:1.3em;" alt="">
            </td>
            <td style="padding-right:2em;">
              The safety and scientific validity of this study is the 
responsibility of the study sponsor and investigators. Listing a study 
does not mean it has been evaluated by the U.S. Federal Government.
                            Read our <a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
          </tr>
        </tbody></table>
      </div>      </div> 
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT01234532</div>
-->
  <div class="w3-col m1">&nbsp;</div> 
  <div class="w3-col m5">   <table style="width:95%">
  <tbody><tr><td>ClinicalTrials.gov Identifier: NCT01234532</td>
  </tr>
  <tr><td>
      
       
              <div class="tr-status tr-not-recruiting-colors">
                        <span style="display:inline;" class="term" data-term="recruitment status" title="Show definition" tabindex="0">Recruitment Status <i class="fa fa-info-circle term" aria-hidden="true" data-term="recruitment status" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> : 
                    Terminated
                  
      <!--
        <div class="tr-status-details">(low accrual)
-->
        (low accrual)
                
  <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="first posted" title="Show definition" tabindex="0">First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> : November 4, 2010</div>
    <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="last update posted" title="Show definition" tabindex="0">Last Update Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="last update posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> : October 4, 2017</div>

  
  <!--
    </div> 
-->
      </div>
  </td>
  </tr>
  </tbody></table>
  </div>
  </div>


                <div class="tr-info-title">Sponsor:</div>
                <div class="tr-info-text" id="sponsor"> University of Maryland, College Park </div>
                <div class="tr-info-title">Collaborator:</div>
                                  				  				                                    <div class="tr-info-text" id="sponsor1">Syndax Pharmaceuticals</div> 
                  				  
                              <div class="tr-info-title">Information provided by (Responsible Party):</div>
                <div class="tr-info-text" id="responsibleparty">Katherine Tkaczuk, University of Maryland, College Park</div>
              	</div>
<br>

    
<div id="tabs">
    <ul id="tab-links">
		<li id="full-text"><a href="https://clinicaltrials.gov/ct2/show/study/NCT01234532">Study Details</a></li>
		<li id="tabular"><a href="https://clinicaltrials.gov/ct2/show/record/NCT01234532">Tabular View</a></li>
  					<li id="results" class="current"> Results Submitted</li>
				<li id="disclaimer"><a title="Disclaimer - opens new window" href="https://clinicaltrials.gov/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false">Disclaimer</a></li>
		<li id="howtoread"><a title="How to Read a Study Record - opens new window" href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false">How to Read a Study Record</a></li>
    </ul>
</div>  <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->

  <div id="tab-body" style="background-color:white;">
  <div class="tr-indent2">

    <!-- Title section -->
    <div class="tr-indent3 ct-inner_content_wrapper" style="text-align:center;">
    
  
  <div class="ct-header1" style="margin:0 0 2px">
          Results Submitted - Not Posted on ClinicalTrials.gov
          </div>

      <div class="tr-noResults w3-left-align">
        Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet 
        publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending 
        <span style="display:inline;" class="term" data-term="quality control (qc) review" title="Show definition" tabindex="0">Quality Control (QC) Review <i class="fa fa-info-circle term" aria-hidden="true" data-term="quality control (qc) review" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>         by the National Library of Medicine (NLM) or if issues identified during 
        QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review 
        assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific 
        validity or relevance of the submitted information.
    </div>
  
  <table class="ct-data_table" style="margin:auto;margin-top:3ex;">
    <tbody><tr>
      <th class="ct-header3 w3-right-align ct-nowrap"> 
                        <span style="display:inline;" class="term" data-term="recruitment status" title="Show definition" tabindex="0">Recruitment Status <i class="fa fa-info-circle term" aria-hidden="true" data-term="recruitment status" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> : 
                </th>
      <td class="ct-body3 w3-left-align">
                                            Terminated
                          </td>
    </tr>

    <tr>
      <th class="ct-header3 w3-right-align ct-nowrap"> 
       Actual       <span style="display:inline;" class="term" data-term="primary completion date" title="Show definition" tabindex="0">Primary Completion Date <i class="fa fa-info-circle term" aria-hidden="true" data-term="primary completion date" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> :
      </th>
      <td class="ct-body3 w3-left-align">
                    May 2017 
              </td>
    </tr>

    <tr>
      <th class="ct-header3 w3-right-align ct-nowrap"> 
       Actual       <span style="display:inline;" class="term" data-term="study completion date" title="Show definition" tabindex="0">Study Completion Date <i class="fa fa-info-circle term" aria-hidden="true" data-term="study completion date" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span> :
      </th>
      <td class="ct-body3 w3-left-align">
                    May 2017
              </td>
    </tr>

    
  </tbody></table>
 

  
  <div style="margin-top:4ex;">
  <table class="ct-data_table" style="padding:5px;border-spacing:0;margin:auto;">
    <thead>
     <tr>
      <th class="ct-header3" style="vertical-align:middle;white-space:nowrap;">Submission Cycle</th>
      <th class="ct-header3" style="vertical-align:middle;">
      <span style="display:inline;" class="term" data-term="results submitted to clinicaltrials.gov" title="Show definition" tabindex="0">Results Submitted to ClinicalTrials.gov <i class="fa fa-info-circle term" aria-hidden="true" data-term="results submitted to clinicaltrials.gov" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>       </th>
      <th class="ct-header3" style="vertical-align:middle;">
      <span style="display:inline;" class="term" data-term="results returned after quality control review" title="Show definition" tabindex="0">Results Returned after Quality Control Review <i class="fa fa-info-circle term" aria-hidden="true" data-term="results returned after quality control review" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>       </th>
     </tr>
    </thead>
    <tbody>
            
      
        
                                        
                        <tr style="vertical-align:middle">
            <th class="ct-header3" style="vertical-align:middle;white-space:nowrap;">1</th>
                    
                                                   <td style="vertical-align:bottom;white-space:nowrap;">
                            November 5, 2019<br>
  
                                                     (<span style="display:inline;" class="term" data-term="canceled submission" title="Show definition" tabindex="0">Canceled <i class="fa fa-info-circle term" aria-hidden="true" data-term="canceled submission" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>                                on November 5, 2019)<br>
                                      
        
                                        
          
                                                                                         November 5, 2019<br>
  
                                                                  </td>                             <td style="vertical-align:bottom;white-space:nowrap;">
                 November 22, 2019                               </td>
              </tr>
                                        </tbody>
    </table>
    </div>


  <div class="tr-noResults w3-left-align">

    
    
      </div>
  
  <br>
    </div>
  
  </div>
  <div id="to-top"><a href="#wrapper">To Top</a></div>
  </div>

  <div style="clear:both;"></div>
</div> 


<div>       <div id="for-footer">
        <ul class="ct-horz-list">
            <li style="border-left:0;"><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

</div>  
<div id="footer-menu">
    <ul class="ct-horz-list">
		<li><a href="https://clinicaltrials.gov/ct2/home">Home</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/sitemap">Site Map</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
		<li><a href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT01234532" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT01234532'); return false">Customer Support</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="ct-horz-list">
		<li><a title="NLM copyright information - opens new window" href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false">Copyright</a></li>
		<li><a title="NLM privacy policy - opens new window" href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false">Privacy</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
		<li><a title="NLM viewers and players - opens new window" href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false">Viewers and Players</a></li>
		<li><a title="NIH Freedom of Information Act office - opens new window" href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false">Freedom of Information Act</a></li>
		<li><a title="USA.gov - opens new window" href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false">USA.gov</a></li>
	</ul>
    <ul class="ct-horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window" href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false">U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window" href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false">U.S. National Institutes of Health</a></li>
       <li><a title="U.S. Department of Health and Human Services - opens new window" href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false">
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

<script type="text/javascript">__ncbi_sg_gaMode="clinicaltrials"</script>
<script type="text/javascript" src="reportedlate_cancelledresubmitted_same_day_files/instrumentNCBIBaseJS.js"></script><noscript></noscript>
<script type="text/javascript" src="reportedlate_cancelledresubmitted_same_day_files/main-glossary.js"></script><noscript></noscript>
<script type="text/javascript">
//OnSubmit routine - copy over some useful data and submit
function sendSearchPing() {
// Get pinger values
var cVals = ncbi.sg.getInstance()._cachedVals;
var app = cVals['ncbi_app'];
var db = cVals['ncbi_db'];
var pdid = cVals['ncbi_pdid'];
var pcid = cVals['ncbi_pcid'];
// Populate search details
var searchDetails = {};
searchDetails['jsevent'] = 'search';
searchDetails['searchtext'] = jQuery('#header-search-query').val();
if (app!=null) searchDetails['ncbi_app'] = app.value;
if (db!=null) searchDetails['ncbi_db'] = db.value;
if (pdid!=null) searchDetails['ncbi_pdid'] = pdid.value;
if (pcid!=null) searchDetails['ncbi_pcid'] = pcid.value;
// Send ping msg
ncbi.sg.ping(searchDetails);
};
</script>




<script type="text/javascript" src="reportedlate_cancelledresubmitted_same_day_files/a"></script></body></html>